Log in

Relevant bibliographies by topics / Candidal vulvovaginitis / Journal articles

To see the other types of publications on this topic, follow the link: Candidal vulvovaginitis.

Journal articles on the topic 'Candidal vulvovaginitis'

Author: Grafiati

Published: 28 May 2022

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Candidal vulvovaginitis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

SOBEL, JACK D. "Candidal Vulvovaginitis." Clinical Obstetrics and Gynecology 36, no. 1 (1993): 153–65. http://dx.doi.org/10.1097/00003081-199303000-00021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Ziyadullaev, U. Kh. "Cytokine profile in adolescent girls with candidal vulvovaginitis." Kazan medical journal 94, no. 6 (2013): 817–20. http://dx.doi.org/10.17816/kmj1797.

Full text

Abstract:

Aim. To establish the pathogenic value of serum cytokine (interleukin-6 and interleukin-8) production in patients with candidal vulvovaginitis to optimize diagnostic and therapeutic approaches. Methods. 74 adolescent girls suffering from candidal vulvovaginitis aged from 12 to 19 years were examined. The diagnosis of candidal vulvovaginitis was verified according to the international classification of World Health Organization (ICD-X codes B37.3 and N77.1). At the stage of clinical examination, medical and general history was analyzed, general and gynecological examination was performed. The d

APA, Harvard, Vancouver, ISO, and other styles

3

Friedrich, Eduard G. "Current perspectives in candidal vulvovaginitis." American Journal of Obstetrics and Gynecology 158, no. 4 (1988): 985–86. http://dx.doi.org/10.1016/0002-9378(88)90107-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Dzhangishieva, A. K., E. P. Khashchenko, and E. V. Uvarova. "Candidal vulvovaginitis in girls: clotrimazole as the drug of choice." Medical Council, no. 13 (October 10, 2019): 10–14. http://dx.doi.org/10.21518/2079-701x-2019-13-10-14.

Full text

Abstract:

The article presents the results of a study on the effectiveness of using clotrimazole 2% to treat candidal vulvovaginitis in girls. The use of a clotrimazole 2% cream treatment regimen, (100 mg), intravaginally once daily in girls with candidal vulvovaginitis is justified and highly effective. The absence of side effects while taking clotrimazole increases the commitment to this type of therapy.

APA, Harvard, Vancouver, ISO, and other styles

5

Nazarko, Linda. "Managing recurrent candidal vulvovaginitis in primary care." Independent Nurse 2019, no. 3 (2019): 30–33. http://dx.doi.org/10.12968/indn.2019.3.30.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Boyd Tressler, A., C. Fortin, M. Radeva, and O. Goje. "Risk factors for non-albicans candidal vulvovaginitis." American Journal of Obstetrics and Gynecology 219, no. 6 (2018): 651. http://dx.doi.org/10.1016/j.ajog.2018.10.056.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Tressler, Andrea Boyd, Chelsea Fortin, Milena Radeva, and Oluwatosin Goje. "371. Risk Factors for Non-Albicans Candidal Vulvovaginitis." Open Forum Infectious Diseases 5, suppl_1 (2018): S145. http://dx.doi.org/10.1093/ofid/ofy210.382.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Dobrokhotova, Yu E., E. I. Borovkina, M. V. Burdenko, and S. E. Kovler. "Recurrent candidal vulvovaginitis: modern tactics of patient management." Obstetrics and gynecology: News, Opinions, Training 13, s (2025): 131–36. https://doi.org/10.33029/2303-9698-2025-13-suppl-131-136.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Rawat, Sangeeta, Rajender Singh, and Garima Mittal. "Phenotypic characterization and antifungal susceptibility profile of Candida isolates from women with vulvovaginal candidiasis at a community health center linked to a teaching institution in the Sub-Himalayan region of North India." Journal of Family Medicine and Primary Care 12, no. 12 (2023): 3326–31. http://dx.doi.org/10.4103/jfmpc.jfmpc_1082_23.

Full text

Abstract:

Introduction: Vulvovaginal candidiasis (VVC) is considered a common gynecological problem among females of reproductive age group. 70–75% of women report having had candidal vulvovaginitis at some point in their lifetimes and 40–50% suffer recurrent candidal vulvovaginitis. Objectives: This study aims to identify the Candida species involved in VVC and to determine their antifungal susceptibility pattern. Materials and Methods: The present study was a cross-sectional study conducted on 257 females (18–55 yr) with complaints of abnormal vaginal discharge. For detection of Candida, the swab samp

APA, Harvard, Vancouver, ISO, and other styles

10

Silverman, Neil S., Margie Morgan, and W. S. Nichols. "Candida lusitaniaeas an Unusual Cause of Recurrent Vaginitis and its Successful Treatment With Intravaginal Boric Acid." Infectious Diseases in Obstetrics and Gynecology 9, no. 4 (2001): 245–47. http://dx.doi.org/10.1155/s1064744901000400.

Full text

Abstract:

Increasing use of short-course antifungal therapies in patients with recurrent vulvovaginitis may enable the emergence of less-common, more resistant yeast strains as vaginal pathogens. We report the case of a patient with chronically symptomatic and repeatedly treated vaginal candidiasis whose infection was attributable toCandidalusitaniae, a previously unreported cause of candidal vaginitis .

APA, Harvard, Vancouver, ISO, and other styles

11

Kokoeva, D. N., M. K. Medzhidova, N. A. Lomova, N. E. Kan, and V. L. Tyutyunnik. "Prevention of premature birth in pregnant women with vaginal candidiasis." Medical Council, no. 7 (April 5, 2019): 52–57. http://dx.doi.org/10.21518/2079-701x-2019-7-52-56.

Full text

Abstract:

Candida vulvovaginitis is an infectious lesion of the vulvar and vaginal mucosa caused by Candida yeast fungi. Vaginal candidiasis during pregnancy is associated with spontaneous miscarriages, premature rupture of the fetal membranes, premature birth, and low birth weight babies. Considering the potential risk of premature delivery at fungal invasion at the level of the lower reproductive tract of a pregnant woman, the search for a complex of preventive measures and timely treatment of сandida vulvovaginitis during gestation is of particular interest. The article presents the results of the us

APA, Harvard, Vancouver, ISO, and other styles

12

Hassan, Nazia, Salma Firdaus, Santwana Padhi, Asgar Ali, and Zeenat Iqbal. "Investigating natural antibiofilm components: a new therapeutic perspective against candidal vulvovaginitis." Medical Hypotheses 148 (March 2021): 110515. http://dx.doi.org/10.1016/j.mehy.2021.110515.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Kostyuk, Irina. "The state of local immunity is at inflammatory diseases of cervix and vagina." Perinatology and reproductology: from research to practice 2, no. 4 (2022): 50–56. https://doi.org/10.52705/2788-6190-2022-04-5.

Full text

Abstract:

The objective: to estimate the state of local immunity at the inflammatory diseases of cervix and vagina. Materials and methods. 9 type groups were selected: I –generally healthy (42 women), II – carriage of candida (45 women), III – bacterial vaginosis (112 women), IV is a heterospecific vulvovaginitis (107 women), V – acute vulvovaginal candidiasis (61 women), VI – chronic vulvovaginal candidiasis (76 women), VII – bacterial vaginosis + candida infection (71 woman), VIII – heterospecific vulvovaginitis + candida infection (84 women), IX – bacterial vaginosis + heterospecific vulvovaginitis (

APA, Harvard, Vancouver, ISO, and other styles

14

Giraldo, P. C., A. D. Ribeiro-Filho, J. A. Simões, A. Neuer, S. B. N. Feitosa, and S. S. Witkin. "Circulating Heat Shock Proteins in Women With a History of Recurrent Vulvovaginitis." Infectious Diseases in Obstetrics and Gynecology 7, no. 3 (1999): 128–32. http://dx.doi.org/10.1155/s1064744999000204.

Full text

Abstract:

Objective:Predisposing factors influencing recurrences of bacterial vaginosis (BV) or vaginitis fromCandidaremain unidentified for most women. As a component of studies to determine host susceptibility factors to genital tractiiafeetions in women, we measured expression of the 60-kDa and 70-kDa heat shock proteins (hsp60 and hsp70, respectively) in the circulation of women with or without a history of recurrent BV or candidal vaginitis and with or without a current lower genital tract infection. Heat shock protein expression is associated with a down-regulation of proinflammatory immune respon

APA, Harvard, Vancouver, ISO, and other styles

15

Т., Г. Романенко, Ю. Стаселович Л., and М. Суліменко О. "RATIONAL THERAPY OF CANDIDOUS VULVOVAGINITIS IN PREGNANCY." REPRODUCTIVE ENDOCRINOLOGY, no. 53 (June 30, 2020): 105–8. https://doi.org/10.18370/2309-4117.2020.53.105-108.

Full text

Abstract:

Objective of the study: was to evaluate the efficacy and safety of the Clofan® drug (clotrimazole, vaginal suppositories 500 mg) for treatment of candidiasis vulvovaginitis (CVV) in the third trimester with multiple pregnancy after using assisted reproductive technologies. Materials and methods. 32 women with multiple pregnancies were examined after using assisted reproductive technologies with CVV symptoms in the third trimester. General clinical research methods, vaginal smear microscopy, and culture studies using culture media were used to confirm the diagnosis. Spores and yeast fungal

APA, Harvard, Vancouver, ISO, and other styles

16

Carvalho de Paula, Heloísa Fernanda. "Candidiasis vulvovaginal en mujeres embarazadas." SCT Proceedings in Interdisciplinary Insights and Innovations 2 (June 11, 2024): 327. http://dx.doi.org/10.56294/piii2024327.

Full text

Abstract:

Introduction: Vulvovaginal candidiasis (VVC) is a candidiasis of the vulva, which is caused by species of Candida spp., and affects women worldwide. Pregnant women are more susceptible to CVV due to certain risk factors. In addition, it predisposes to premature birth. Objectives: To analyze the risk factors for vaginal candidiasis in pregnancy and highlight the importance of treating vaginal candidiasis during pregnancy as a risk prevention strategy for premature rupture of the membrane and preterm labor. Material and methods: A bibliographic, descriptive and retrospective review was carried o

APA, Harvard, Vancouver, ISO, and other styles

17

Arrieta-Aguirre, Inés, Pilar Menéndez-Manjón, Giulia Carrano, Ander Diez, Íñigo Fernandez-de-Larrinoa, and María-Dolores Moragues. "Molecular Identification of Fungal Species through Multiplex-qPCR to Determine Candidal Vulvovaginitis and Antifungal Susceptibility." Journal of Fungi 9, no. 12 (2023): 1145. http://dx.doi.org/10.3390/jof9121145.

Full text

Abstract:

Vulvovaginal candidiasis (VVC) is a prevalent condition affecting women worldwide. This study aimed to develop a rapid qPCR assay for the accurate identification of VVC etiological agents and reduced azole susceptibility. One hundred and twenty nine vaginal samples from an outpatient clinic (Bilbao, Spain) were analyzed using culture-based methods and a multiplex qPCR targeting fungal species, which identified Candida albicans as the predominant species (94.2%). Antifungal susceptibility tests revealed reduced azole susceptibility in three (3.48%) isolates. Molecular analysis identified severa

APA, Harvard, Vancouver, ISO, and other styles

18

Maftei, Nicoleta-Maricica, Manuela Arbune, Costinela Valerica Georgescu, Alina Mihaela Elisei, Alina Viorica Iancu, and Alin Laurentiu Tatu. "Vulvovaginal Candidiasis in Pregnancy—Between Sensitivity and Resistance to Antimycotics." Journal of Xenobiotics 13, no. 3 (2023): 312–22. http://dx.doi.org/10.3390/jox13030023.

Full text

Abstract:

Vulvovaginitis with Candida spp. is the most common infection in women and the rate is increased during pregnancy. Antifungal prescription in pregnant women continues to present challenges and the decision must balance the risk of fetal toxicity with the benefits to the fetus and mother. Starting from the idea that clotrimazole is the most recommended antifungal in candidal vaginitis in pregnancy, we tested the sensitivity of different species of Candida spp. to other azoles, polyenes, and antimetabolites. This retrospective study (January to June 2019) assessed 663 pregnant women hospitalized

APA, Harvard, Vancouver, ISO, and other styles

19

Tilak, Ragini, Varsha Kumari, Tuhina Banerjee, Pankaj Kumar, and Sulekha Pandey. "Emergence of non-albicans Candida among candidal vulvovaginitis cases and study of their potential virulence factors, from a tertiary care center, North India." Indian Journal of Pathology and Microbiology 56, no. 2 (2013): 144. http://dx.doi.org/10.4103/0377-4929.118703.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Loendersloot, E. W., E. Goormans, P. E. Wiesenhaan, P. J. Barthel, and J. H. Branolte. "Efficacy and tolerability of single-dose versus six-day treatment of candidal vulvovaginitis with vaginal tablets of clotrimazole." American Journal of Obstetrics and Gynecology 152, no. 7 (1985): 953–55. http://dx.doi.org/10.1016/s0002-9378(85)80008-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Fatahinia, Mahnaz, Shirin Jaldani, Elham Maraghi, Eskandar Moghimipour, and Mojgan Javadnoori. "Comparison of the effectiveness of Satureja khuzestanica and clotrimazole vaginal creams for the treatment of vulvovaginal candidiasis." Journal of Medicine and Life 14, no. 1 (2021): 111–17. http://dx.doi.org/10.25122/jml-2020-0014.

Full text

Abstract:

Candidal vaginitis has a relatively high prevalence, and its resistance to treatment is on the rise. Considering the complications of chemical drugs, the use of herbal medicines has now been favored due to the lack of changes in the normal vaginal flora. The aim of this study was to compare the effectiveness of Satureja khuzestanica and clotrimazole vaginal creams for the treatment of candidal vulvovaginitis. A randomized clinical trial was conducted on 84 reproductive-aged women in the city of Ahvaz, Iran. Individuals were randomly divided into two treatment groups: 1% Satureja khuzestanica v

APA, Harvard, Vancouver, ISO, and other styles

22

Priyanka, Sondarva, and Vaghela Amit. "An Observational Study of Cutaneous Manifestations Associated with Diabetes Mellitus." International Journal of Pharmaceutical and Clinical Research 15, no. 12 (2023): 1448–53. https://doi.org/10.5281/zenodo.11204125.

Full text

Abstract:

<strong>Background and Aim: </strong>The pathophysiology of diabetes mellitus and its effects on the human body have been well analysed over the years. Nevertheless, the skin, which is the biggest organ in the body, has been given minimal attention. The purpose of this study was to determine the various skin symptoms observed in diabetic patients. <strong>Material and Methods:</strong> A cohort of 180 diabetes patients with cutaneous symptoms, who visited the skin outpatient department (OPD) at a prestigious teaching hospital in India over a period of 1 year, were chosen by a ra

APA, Harvard, Vancouver, ISO, and other styles

23

О., В. Кравченко. "VULVOVAGINITIS THERAPY IN PREGNANT WOMEN AS A PREVENTATIVE METHOD OF THE PERINATAL COMPLICATIONS DEVELOPMENT." REPRODUCTIVE ENDOCRINOLOGY, no. 48 (August 29, 2019): 56–58. https://doi.org/10.18370/2309-4117.2019.48.56-58.

Full text

Abstract:

Disorders of the vaginal biocenosis in pregnant women takes the leading place in the etiology of the main obstetric and perinatal complications. Careful attention to the biocenosis of pregnant woman is also due to the fact that the formation of fetus bacterial communities occurs long before its birth. Purpose of the study. Evaluation of the effectiveness of chlorine-containing antiseptics for vulvovaginal infections during pregnancy as a method for the prevention of perinatal complications. Materials and methods. 62 pregnant women in the second and third trimester of gestation were examined. A

APA, Harvard, Vancouver, ISO, and other styles

24

Zuev, V. M., D. G. Gulenkova, I. L. Goldman, E. R. Sadchikova, and M. T. Aleksandrov. "LACTOFERRIN, FLUORESCENT TECHNOLOGIES AND THEIR ROLE IN THE DIAGNOSIS AND TREATMENT OF INFLAMMATORY DISEASES OF THE FEMALE SEXUAL SPHERE." V.F.Snegirev Archives of Obstetrics and Gynecology 5, no. 2 (2018): 101–5. http://dx.doi.org/10.18821/2313-8726-2018-5-2-101-105.

Full text

Abstract:

The article reflects a modern view on the introduction of fluorescent methods of diagnostics and treatment of vaginal infections using lactoferrin in clinical microbiology, which made it possible to expand microecological studies. The suppression of the normal vaginal microflora was shown to promote a diverse pathology of both inflammatory and non-inflammatory genesis. Bacterial and fungal vaginosis were proved to be the most important risk factors for the development of infectious complications in the gynecological practice. There are given substantiated scientific evidence, indicating a larg

APA, Harvard, Vancouver, ISO, and other styles

25

Pandei, Svitlana, Dmytro Ledin, and Oleksandra Lubkovska. "VULVOVAGINAL CANDIDIASIS IN COMBINATION WITH BACTERIAL VAGINOSIS IN WOMEN OF REPRODUCTIVE AGE: FEATURES OF PATHOGENESIS AND TREATMENT." EUREKA: Health Sciences, no. 1 (January 30, 2021): 12–17. https://doi.org/10.21303/2504-5679.2021.001624.

Full text

Abstract:

The aim. Reducing the recurrence of vulvovaginal candidiasis (VVC) in combination with bacterial vaginosis (BV) in women of reproductive age by studying the pathogenesis and improving the algorithm of treatment and prevention measures. Materials and methods. During the study, 150 women of reproductive age who had the same clinical manifestations of VVC and BV were selected and divided into 3 groups of 50 women: Group I was treated with an antimicrobial combination drug (miconazole with topical metronidazole), group II – the same drug in combination with probiotic (lactobacilli) in candles, gro

APA, Harvard, Vancouver, ISO, and other styles

26

Wei, Tao, Hua Wang, and Boyang Wen. "Comparison of copper IUDs and hormonal IUDs in prevalence of Candida species in cervicovaginal smears." Cellular and Molecular Biology 67, no. 4 (2022): 130–34. http://dx.doi.org/10.14715/cmb/2021.67.4.15.

Full text

Abstract:

Candidal vulvovaginitis is one of the most common genital infections that different types of diagnosis are essential for a proper treatment plan. IUD is one of the most influential and long-lasting methods of contraception that can be associated with vaginal candidiasis. This study was performed to investigate the prevalence of Candida species before and three months after IUD placement in patients referred to health centers. Also, a comparison of copper IUDs and hormonal IUDs was evaluated to consider the prevalence of Candida species in cervicovaginal smears. In this regard, cervicovaginal s

APA, Harvard, Vancouver, ISO, and other styles

27

Sanjaya, I. Nyoman Hariyasa, and Cokorda istri Mirayani Pemayun. "Vaginal Ozone Insufflation in Management of Vaginal Candidiasis." European Journal of Medical and Health Sciences 5, no. 5 (2023): 13–16. http://dx.doi.org/10.24018/ejmed.2023.5.5.1414.

Full text

Abstract:

The vagina of a woman is a sophisticated microecology system. Typically, the H2O2-producing Lactobacillus dominates the vaginal microbiota of healthy women. This bacterium converts glycogen in vaginal epithelial cells into lactic acid, sustaining the vagina's natural acidic environment. Understanding the substantial correlation between the vaginal and upper genital tract microbiota and vaginal and genital tract infections has led to an interest in these areas. However, the spectrum of microbial types consistent with a functioning genital tract and the variables influencing the flora remains pe

APA, Harvard, Vancouver, ISO, and other styles

28

Firdaus, Salma, Nazia Hassan, Mohd Aamir Mirza, et al. "FbD directed fabrication and investigation of luliconazole based SLN gel for the amelioration of candidal vulvovaginitis: a 2 T (thermosensitive & transvaginal) approach." Saudi Journal of Biological Sciences 28, no. 1 (2021): 317–26. http://dx.doi.org/10.1016/j.sjbs.2020.10.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Majdabadi, Niloufar, Mehraban Falahati, Fariba Heidarie-Kohan, et al. "Effect of 2-Phenylethanol as Antifungal Agent and Common Antifungals (Amphotericin B, Fluconazole, and Itraconazole) onCandidaSpecies Isolated from Chronic and Recurrent Cases of Candidal Vulvovaginitis." ASSAY and Drug Development Technologies 16, no. 3 (2018): 141–49. http://dx.doi.org/10.1089/adt.2017.837.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Sobel, Jack D. "Candida vulvovaginitis." Seminars in Dermatology 15, no. 1 (1996): 17–28. http://dx.doi.org/10.1016/s1085-5629(96)80014-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Budilovskaya, Olga V., Elena V. Shipitsyna, Nadezhda A. Pereverzeva, et al. "Comparison of methods for assessing the inflammatory response of the lower parts of the female reproductive tract." Journal of obstetrics and women's diseases 67, no. 5 (2018): 13–20. http://dx.doi.org/10.17816/jowd67513-20.

Full text

Abstract:

Hypothesis/aims of study. A lack of timely diagnosis and treatment of inflammatory diseases of the lower genital tract in a woman can lead to serious reproductive disorders. The detection of inflammation is an important component of the diagnosis of these diseases. This study was undertaken to compare methods for detection of local inflammation in women with complaints of vaginal discharge. Study design, materials, and methods. A total of 87 women having vaginal discharge were enrolled in the study. For the detection of inflammation, vaginal discharge was examined using microscopy and re

APA, Harvard, Vancouver, ISO, and other styles

32

Nsenga, Lauryn, and Felix Bongomin. "Recurrent Candida Vulvovaginitis." Venereology 1, no. 1 (2022): 114–23. http://dx.doi.org/10.3390/venereology1010008.

Full text

Abstract:

Vulvovaginal candidiasis (VVC), predominantly caused by Candida albicans, is estimated to affect about 138 million women each year worldwide and 492 million over their lifetimes. Recurrent VVC (RVVC), defined as four or more episodes of VVC in a year, is increasingly recognized and constitutes up to 10% of the cases of VVC. RVVC is an important clinical and global public health challenge project that will affect about 160 million per year by 2030. RVVC significantly affects the quality of life of the affected women. Host factors, such as underlying immunosuppressive conditions and genetic pred

APA, Harvard, Vancouver, ISO, and other styles

33

Selikhova, M. S. "Role of probiotics in the treatment and prevention of genitourinary infections." Russian Journal of Woman and Child Health 8, no. 2 (2025): 124–27. https://doi.org/10.32364/2618-8430-2025-8-2-5.

Full text

Abstract:

Urinary tract infections (UTIs) represent one of the leading causes of gynecological morbidity and their incidence shows no significant downward trend. A characteristic feature concerning the clinical manifestation of inflammatory diseases in recent years has been a predominantly chronic course, frequently accompanied by relapses. While novel antibacterial agents have demonstrated efficacy in the management of acute infections, their efficacy is markedly reduced in cases of chronic UTIs and they are insufficient in preventing relapse. Over the past 10–15 years, there has been a profound shift

APA, Harvard, Vancouver, ISO, and other styles

34

Powell, Anna M., Edward Gracely, and Paul Nyirjesy. "Non-albicans Candida Vulvovaginitis." Journal of Lower Genital Tract Disease 20, no. 1 (2016): 85–89. http://dx.doi.org/10.1097/lgt.0000000000000126.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Xu, Jinping, and Jack D. Sobel. "Candida vulvovaginitis in pregnancy." Current Infectious Disease Reports 6, no. 6 (2004): 445–49. http://dx.doi.org/10.1007/s11908-004-0063-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

De Silva, P. H. P., S. Lanerolle, H. S. Dodampahala, W. Galapaththy, C. Mathota, and S. A. Karunananda. "Management of candida vulvovaginitis." Sri Lanka Journal of Obstetrics and Gynaecology 44, no. 4 (2022): 249. http://dx.doi.org/10.4038/sljog.v44i4.8077.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Yousif, Eman E., and Sawsan A. Hussien. "Candida Vulvovaginitis in pregnancy." Journal of the Faculty of Medicine Baghdad 52, no. 2 (2010): 183–85. http://dx.doi.org/10.32007/jfacmedbagdad.5221019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Karakhalis, L. Yu, and N. S. Ivantsiv. "Impact of Vaginal Microbiota on Gestation and Labour." Kuban Scientific Medical Bulletin 27, no. 6 (2020): 30–43. http://dx.doi.org/10.25207/1608-6228-2020-27-6-30-43.

Full text

Abstract:

Background. Imbalances of vagina microbiota in pregnant women entail the development of bacterial vaginosis and candidal vulvovaginitis. Lactobacterial strains modulate pro-inﬂammatory epithelium responses to enhance resistance, which renders lactobacteria promising agents in pregnant women with elevated pH.Objectives. Assessment of the lactobacterial impact on vaginal microbiota and the course of gestation and labour.Methods. A total of 261 pregnant women were examined and separated by cohorts according to pH of vaginal ﬂuid: ≥4.5 in cohort 1 (n = 147), <4.5 in cohort 2 (n = 114). Cohort 1

APA, Harvard, Vancouver, ISO, and other styles

39

REED, BARBARA D. "Risk Factors for Candida Vulvovaginitis." Obstetrical & Gynecological Survey 47, no. 8 (1992): 551–60. http://dx.doi.org/10.1097/00006254-199208000-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Marchaim, Dror, Leslie Lemanek, Suchitha Bheemreddy, Keith S. Kaye, and Jack D. Sobel. "Fluconazole-Resistant Candida albicans Vulvovaginitis." Obstetrics & Gynecology 120, no. 6 (2012): 1407–14. http://dx.doi.org/10.1097/aog.0b013e31827307b2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Shulman, L. P. "Fluconazole-Resistant Candida albicans Vulvovaginitis." Yearbook of Obstetrics, Gynecology and Women's Health 2013 (2013): 366–68. https://doi.org/10.1016/j.yobg.2013.05.056.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Dungan, J. S. "Fluconazole-Resistant Candida albicans Vulvovaginitis." Yearbook of Obstetrics, Gynecology and Women's Health 2013 (2013): 361–62. https://doi.org/10.1016/j.yobg.2013.05.206.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Sivagamasundari, S., K. Mahadevan, Reena Rai, and Sriramajayam Lavanya. "A prospective observational study on species differentiation and antifungal susceptibility pattern in patients with genital candidiasis." Indian Journal of Sexually Transmitted Diseases and AIDS 45, no. 1 (2024): 11–14. http://dx.doi.org/10.4103/ijstd.ijstd_58_23.

Full text

Abstract:

Abstract Background: Candidial balanitis, balanoposthitis and vulvovaginitis can be diagnosed by direct microscopy, culture and treated with antifungals. Resistance to antifungals is emerging. Hence, we conducted a study to identify the causative species and antifungal susceptibility. Aim: To observe the species differentiation and antifungal susceptibility pattern in patients with genital candidiasis. Materials and Methods: A prospective observational study was carried out that included 54 patients of age group (18-60 years) diagnosed clinically and direct microscopically (KOH) for genital ca

APA, Harvard, Vancouver, ISO, and other styles

44

Chidinma Princess Ezeamalu, Onyekachukwu Izuchukwu Udemezue, Divine Jacob Ottong, Onyekachi Ijeoma Udemezue, and Joachim Ohiakwu Ezeadila. "Microorganisms implicated in vulvovaginitis among patients attending a teaching hospital in southeastern Nigeria." International Journal of Science and Research Archive 12, no. 2 (2024): 2658–64. http://dx.doi.org/10.30574/ijsra.2024.12.2.1592.

Full text

Abstract:

Vulvovaginitis is a common infection of the vulva and vagina with symptoms such as irritation of the genital area, itching, inflammation around the labia and perineal areas, strong-smelling vaginal discharge and discomfort while urinating. The etiological agents include bacteria, yeast, viruses, parasites, environmental factors, exposure to chemical irritants and allergens. Microorganisms implicated in vulvovaginitis among patients attending a teaching hospital in Southeastern Nigeria were analyzed using standard Microbiological procedures. High vaginal swab (HVS) specimens (100) were properly

APA, Harvard, Vancouver, ISO, and other styles

45

A. Mbogning, Therence, Sonia G. Matchuenkam, Gaizirene E. Feudjieu, et al. "Vulvovaginitis and Associated Factors in Pregnant Women Requesting A Cytobacteriological Examination of Cervical-Vaginal Sampling at the "Si Melon Laboratory" In The City of Yaoundé - Cameroon." International Journal of Current Microbiology and Applied Sciences 13, no. 6 (2024): 107–18. http://dx.doi.org/10.20546/ijcmas.2024.1306.012.

Full text

Abstract:

Vulvovaginitis, a significant public health issue, poses risks during pregnancy. This study identifies the germs causing vulvovaginitis and their associated factors in pregnant women at the Si Melon Laboratory in Yaoundé, Cameroon. In a 04-week study, vaginal secretions from 55 pregnant women were analyzed using Amsel’s criteria, Nugent’s scoring, and culture techniques. Antimicrobial sensitivity was assessed via disc diffusion, with statistical significance set at a p-value ≤ 0.05. Of the 55 women included in this study, 72.7% were carriers of germs involved in vulvovaginitis, and 52.7% were

APA, Harvard, Vancouver, ISO, and other styles

46

WENDLING, PATRICE. "Refractory Candida Vulvovaginitis on the Rise." Family Practice News 41, no. 16 (2011): 28. http://dx.doi.org/10.1016/s0300-7073(11)70855-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Nemes-Nikodém, Éva, Béla Tamási, Noémi Mihalik, and Eszter Ostorházi. "Yeast species in vulvovaginitis candidosa." Orvosi Hetilap 156, no. 1 (2015): 28–31. http://dx.doi.org/10.1556/oh.2015.30081.

Full text

Abstract:

Introduction: Vulvovaginal candidiasis is the most common mycosis, however, the available information about antifungal susceptibilities of these yeasts is limited. Aim: To compare the gold standard fungal culture with a new molecular identification method and report the incidence of yeast species in vulvovaginitis candidosa. Method: The authors studied 370 yeasts isolated from vulvovaginal candidiasis and identified them by phenotypic and molecular methods. Results: The most common species was Candida albicans (85%), followed by Candida glabrata, and other Candida species. Conclusion: At prese

APA, Harvard, Vancouver, ISO, and other styles

48

Donders, Gilbert G. G., Kateryna Ruban, Francesca Donders, and Reinhilde Reybrouck. "Lab-Based Retrospective 10-Year Analysis Shows Seasonal Variation of Vaginal Candida Infection Rates in Belgium." Journal of Clinical Medicine 11, no. 3 (2022): 574. http://dx.doi.org/10.3390/jcm11030574.

Full text

Abstract:

Candida vulvovaginitis is a frequent condition, and although several risk factors are known, its behavior is still enigmatic. The seasonal influence of climate conditions and living habits on its prevalence was studied. In a retrospective lab-based cohort over 10 years, we studied the prevalence of Candida in 12,941 vaginal cultures taken from women attending a vulvovaginitis clinic. The prevalence of non-albicans and albicans species were compared per month to detect differences in positivity rates in summer versus winter months. Chi-square and chi-square for trend were used. Of the 2109 (16.

APA, Harvard, Vancouver, ISO, and other styles

49

Reed, Barbara D. "Candida Vulvovaginitis and Vulvodynia: The Mystery Continues." Journal of Women's Health 26, no. 10 (2017): 1045–46. http://dx.doi.org/10.1089/jwh.2017.6620.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Fakhim, H., A. Vaezi, J. Javidnia, et al. "Candida africana vulvovaginitis: Prevalence and geographical distribution." Journal de Mycologie Médicale 30, no. 3 (2020): 100966. http://dx.doi.org/10.1016/j.mycmed.2020.100966.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!